We cordially invite our valued customers and suppliers to join us at DCAT Week 2023, taking place from March 21st to 24th in New York City.
This premier event is a great opportunity for us to showcase our products and services, as well as to connect with industry leaders and innovators. We look forward to seeing you there and discussing how we can continue to support your success.

Our sales and technical service teams are ready to meet you at SupplySide West 2021.

We are happy to welcome Martha Futterman-Troop to the CapsCanada team, where she will lead as the new Director of Sales and Business Development for OTC and Pharma.

DANIA BEACH, FL March 5, 2021—CapsCanada, a Lyfe Group^™ company and leader in capsule technology for over three decades, is pleased to announce the launch of a new liquid-filled hard capsule manufacturing service. CapsCanada’s objective is to support the entire manufacturing process, from formulation and development through full-scale production. In creating this service CapsCanada partnered with one of the leading manufacturers of generic and branded drugs in Canada. Production will be done at a dedicated Health Canada approved facility in Canada that has a full analytical lab, licensing for controlled drugs and substances including narcotics and a choice of blister or bottle packaging.  The facility is also US FDA approved and cGMP compliant for the manufacture and testing of injectables and is currently awaiting US FDA approval for the manufacture and testing of solid oral dosage forms.

We are happy to announce that the Canadian facility in Windsor, Ontario has a new leader in charge. Tom Breshamer has been promoted from Operations Manager to General Manager.